For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 8

Based on the information you provided, we found the following studies.

  • A Phase 1 Dose-Escalation Study of RRx-001 in Combination with Whole Brain Radiation in Subjects with Brain Metastases The study purpose is to test the safety and efficacy of whole brain radiation therapy with RRx-001, an experimental radiation sensitizer, in participants with brain metastases, to see whether RRx-001 may act as a "magnifying glass" to increase the effect of whole brain radiation on cancer cells. This study is researching all of the following topics: Brain cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1/ 2 Study of BMN 673, an Oral Poly(ADP-ribose) Polymerase Inhibitor, Plus Temozolomide in Children with Refractory or Recurrent Malignancies Study goals: find highest safe dose of temozolomide that can be given with experimental drug BMN 673 without causing severe side effects; learn side effects BMN 673 can cause; learn side effects BMN 673/temozolomide combination can cause; learn how your body handles BMN 673/temozolomide combination This study is researching all of the following topics: Brain cancer Leukemia Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 1 years old
    • Less than 21 years old
  • PHASE 1/2 STUDY OF MK-1775 (AZD1775, IND# 121422) IN COMBINATION WITH ORAL IRINOTECAN IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SOLID TUMORS Goals: find the highest tolerable dose of MK-1775 in combination with irinotecan that can be given without causing severe side effects; learn what kind of side effects the combination can cause; learn how your body handles MK-1775;learn about biology of MK-1775 in blood, bone marrow or tumor tissue This study is researching all of the following topics: Brain cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • 1 years to 21 years
  • A Phase 1 Study of MK-1775 (IND# 116495) Concurrent With Local Radiation Therapy for the Treatment of Newly Diagnosed Children with Diffuse Intrinsic Pontine Gliomas (DIPG) Goals:find safest child dose of MK-1775 given with radiation therapy without causing severe side effects;learn side effects caused by MK-1775 with radiation therapy;learn how body handles MK-1775 and biology effects of MK-775 on body's cells;determine if MK-1775 with radiation therapy is beneficial. This study is researching all of the following topics: Brain cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • Less than 21 years old
    • More than 3 years old
  • A Phase 1b, Open-label Study of Oral BGJ398 in Combination with Oral BYL719 in Adult Patients with Select Advanced Solid Tumors This clinical research study is to determine how much of experimental drugs BGJ398 and BYL719 can safely be given in combination to patients. Researchers would like to know how much of these two drugs can be given without causing serious side effects and also how these two drugs affect your body. This study is researching all of the following topics: Brain cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children with Primary Brain Tumors This is a non-therapeutic study to measure changes after standard treatment for brain cancer in children. Young adults & children with parents who consent will undergo 3 diffusion MRIs over a 6-month period, and tested for fatigue and cognitive changes. Potential benefit to know and manage cancer. This study is researching all of the following topics: Brain cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 6 years old
    • Less than 21 years old
  • A T1 translational multicenter randomized phase II study of Temsirolimus The purpose of this study is to learn if temsirolimus (TORISEL®) alone or in combination with cetuximab (ERBITUX®) can potentially have an effect on head and neck cancers in people who were previousl This study is researching all of the following topics: Brain cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier Researchers are hoping to gain knowledge about the impact of radiation therapy to the brain through MRI's and neurocognitive assessments. This study is researching all of the following topics: Brain cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old